Fundraising Fox
/Companies
Sign in

EditPep

Berkeley, US · Founded 2022 · Delaware corporation · 1 known investors

Find your way into EditPep

Each arrow is one introduction. Sign up to fill in the first one.

40 people can intro you to Dana

Ask Genine Winslow to introduce you to Dana Foss

You →Genine · together at EditPep →Dana

Sign up to find every way you can get introduced to EditPep

  • Your email: who you already know at EditPep, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the EditPep team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

A Berkeley spinout developing a new generation of medicines for the brain and other hard-to-treat tissues using breakthrough science from UC Berkeley and the Innovative Genomics Institute.

Biotech

Founders & leadership

EditPep was founded in 2022 by Ross Wilson and Dana Foss.

RW
Ross WilsonCo-founder
DFDana Foss
Dana FossCo-founder and Chief Executive OfficerDana Foss is a biochemist with expertise in protein engineering, RNA biology, and CRISPR-based therapeutic delivery. She leads EditPep, a company developing therapeutics for the brain and hard-to-treat tissues using technology from UC Berkeley and the Innovative Genomics Institute.

Board

JT
Jaromir TesarBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$8.2M disclosed across 1 round · 2024

▶$8.2MraisedDec 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ross WilsonExecutive Officer, Director, Promoter
  • Dana FossExecutive Officer, Director, Promoter
  • Jaromir TesarDirector
Offering amount
$8.2M
Amount sold
$8.2M
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does EditPep do?
A Berkeley spinout developing a new generation of medicines for the brain and other hard-to-treat tissues using breakthrough science from UC Berkeley and the Innovative Genomics Institute.
Who founded EditPep?
EditPep was founded by Ross Wilson, Dana Foss in 2022.
Who are EditPep's investors?
EditPep's investors include CALIFORNIA INNOVATION.
How much funding has EditPep raised?
EditPep has disclosed $8.2M raised across 1 round.
Where is EditPep headquartered?
EditPep is headquartered in Berkeley, US.